Best TWAS P=2.86e-19 · Best GWAS P=4.36e-17 conditioned to 0.373
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | POMT2 | 0.11 | 0.01 | bslmm | 553 | 0.02 | 5.2e-04 | 2.0 | -5.3 | 1.2e-07 | -0.58 | 0.11 | 0.69 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | SAMD15 | 0.11 | 0.11 | lasso | 3 | 0.12 | 7.6e-14 | -7.7 | 7.8 | 7.7e-15 | 0.92 | 0.11 | 0.89 | FALSE |
3 | GTEx | Adipose Subcutaneous | VIPAS39 | 0.07 | 0.06 | lasso | 4 | 0.04 | 3.7e-04 | -7.6 | 7.7 | 1.3e-14 | 0.96 | 0.09 | 0.90 | FALSE |
4 | GTEx | Adipose Subcutaneous | NOXRED1 | 0.14 | 0.06 | lasso | 4 | 0.04 | 3.3e-04 | 7.7 | -6.9 | 6.2e-12 | -0.89 | 0.05 | 0.95 | FALSE |
5 | GTEx | Adrenal Gland | NOXRED1 | 0.24 | 0.15 | lasso | 5 | 0.09 | 3.7e-04 | 8.4 | -7.9 | 2.9e-15 | -0.93 | 0.01 | 0.97 | FALSE |
6 | GTEx | Artery Aorta | TMED8 | 0.17 | 0.06 | lasso | 8 | 0.11 | 1.5e-06 | 3.2 | 6.1 | 1.1e-09 | 0.82 | 0.04 | 0.95 | FALSE |
7 | GTEx | Artery Tibial | TMED8 | 0.12 | 0.02 | enet | 11 | 0.02 | 7.7e-03 | 7.9 | 7.2 | 6.7e-13 | 0.74 | 0.11 | 0.73 | FALSE |
8 | GTEx | Artery Tibial | NOXRED1 | 0.08 | 0.06 | lasso | 7 | 0.04 | 5.0e-04 | -7.6 | -6.8 | 9.5e-12 | -0.94 | 0.03 | 0.96 | FALSE |
9 | GTEx | Brain Hypothalamus | GSTZ1 | 0.35 | 0.17 | lasso | 4 | 0.16 | 1.5e-04 | -4.5 | -5.6 | 2.0e-08 | -0.50 | 0.08 | 0.36 | FALSE |
10 | GTEx | Breast Mammary Tissue | TMED8 | 0.18 | 0.04 | enet | 16 | 0.06 | 4.3e-04 | -6.8 | 6.8 | 1.1e-11 | 0.82 | 0.03 | 0.94 | FALSE |
11 | GTEx | Breast Mammary Tissue | VIPAS39 | 0.08 | 0.02 | enet | 7 | 0.00 | 3.1e-01 | -7.6 | 7.5 | 8.0e-14 | 0.97 | 0.06 | 0.88 | FALSE |
12 | GTEx | Breast Mammary Tissue (Male) | TMED8 | 0.25 | 0.02 | lasso | 5 | -0.01 | 6.1e-01 | 8.4 | 7.5 | 7.7e-14 | 0.91 | 0.04 | 0.60 | FALSE |
13 | GTEx | Cells EBV-transformed lymphocytes | NOXRED1 | 0.32 | 0.20 | lasso | 7 | 0.18 | 1.4e-06 | -7.8 | -7.9 | 3.8e-15 | -0.97 | 0.01 | 0.98 | FALSE |
14 | GTEx | Cells Transformed fibroblasts | NOXRED1 | 0.08 | 0.07 | lasso | 5 | 0.06 | 3.2e-05 | -7.7 | -7.7 | 1.3e-14 | -0.97 | 0.03 | 0.96 | FALSE |
15 | GTEx | Colon Transverse | NOXRED1 | 0.16 | 0.14 | enet | 19 | 0.17 | 1.2e-08 | -7.7 | -7.6 | 3.1e-14 | -0.93 | 0.04 | 0.96 | FALSE |
16 | GTEx | Esophagus Mucosa | TMED8 | 0.23 | 0.09 | lasso | 8 | 0.14 | 8.6e-10 | 8.4 | 6.2 | 5.7e-10 | 0.85 | 0.02 | 0.98 | FALSE |
17 | GTEx | Esophagus Mucosa | NOXRED1 | 0.12 | 0.05 | lasso | 3 | 0.04 | 7.3e-04 | -7.8 | -8.6 | 8.7e-18 | -0.95 | 0.03 | 0.96 | FALSE |
18 | GTEx | Esophagus Muscularis | NOXRED1 | 0.10 | 0.07 | lasso | 4 | 0.06 | 8.8e-05 | 7.7 | -7.3 | 2.4e-13 | -0.93 | 0.03 | 0.96 | FALSE |
19 | GTEx | Lung | TMED8 | 0.16 | 0.16 | enet | 19 | 0.17 | 6.3e-13 | -7.7 | 7.7 | 1.6e-14 | 0.94 | 0.02 | 0.98 | FALSE |
20 | GTEx | Lung | VIPAS39 | 0.08 | 0.02 | enet | 15 | 0.02 | 1.6e-02 | -7.7 | 8.0 | 9.7e-16 | 0.97 | 0.02 | 0.98 | FALSE |
21 | GTEx | Nerve Tibial | TMED8 | 0.27 | 0.20 | enet | 22 | 0.28 | 2.7e-20 | 3.3 | 5.2 | 1.6e-07 | 0.62 | 1.00 | 0.00 | FALSE |
22 | GTEx | Nerve Tibial | VIPAS39 | 0.09 | 0.06 | lasso | 5 | 0.04 | 6.6e-04 | 8.3 | 8.1 | 5.5e-16 | 1.00 | 0.01 | 0.99 | FALSE |
23 | GTEx | Nerve Tibial | NOXRED1 | 0.19 | 0.16 | lasso | 7 | 0.16 | 1.1e-11 | -7.7 | -7.8 | 6.1e-15 | -0.97 | 0.02 | 0.98 | FALSE |
24 | GTEx | Prostate | NOXRED1 | 0.26 | 0.03 | enet | 34 | 0.02 | 1.1e-01 | -7.7 | -6.7 | 1.8e-11 | -0.88 | 0.03 | 0.88 | FALSE |
25 | GTEx | Skin Not Sun Exposed Suprapubic | NOXRED1 | 0.19 | 0.14 | enet | 19 | 0.18 | 4.8e-10 | -7.6 | -7.4 | 1.6e-13 | -0.81 | 0.04 | 0.96 | FALSE |
26 | GTEx | Skin Sun Exposed Lower leg | TMED8 | 0.15 | 0.12 | lasso | 7 | 0.16 | 8.4e-13 | 3.1 | 5.6 | 1.8e-08 | 0.66 | 0.97 | 0.03 | FALSE |
27 | GTEx | Skin Sun Exposed Lower leg | VIPAS39 | 0.14 | 0.14 | lasso | 3 | 0.13 | 8.9e-11 | -7.8 | 7.9 | 2.1e-15 | 0.97 | 0.06 | 0.94 | FALSE |
28 | GTEx | Skin Sun Exposed Lower leg | NOXRED1 | 0.16 | 0.14 | lasso | 6 | 0.14 | 3.0e-11 | -7.6 | -7.5 | 9.2e-14 | -0.92 | 0.09 | 0.91 | FALSE |
29 | GTEx | Spleen | TMED8 | 0.30 | 0.07 | lasso | 6 | 0.15 | 1.1e-04 | -7.6 | 9.0 | 2.9e-19 | 0.89 | 0.07 | 0.74 | TRUE |
30 | GTEx | Testis | VIPAS39 | 0.26 | 0.18 | enet | 13 | 0.15 | 3.4e-07 | -7.8 | 7.6 | 2.1e-14 | 0.97 | 0.09 | 0.91 | FALSE |
31 | GTEx | Thyroid | NOXRED1 | 0.06 | 0.01 | lasso | 9 | 0.00 | 7.6e-01 | -7.6 | -5.3 | 1.4e-07 | -0.76 | 0.03 | 0.90 | FALSE |
32 | GTEx | Whole Blood | TMED8 | 0.14 | 0.09 | enet | 17 | 0.07 | 8.1e-07 | 8.4 | 7.8 | 5.2e-15 | 0.97 | 0.01 | 0.99 | FALSE |
33 | METSIM | Adipose | AHSA1 | 0.03 | 0.01 | blup | 586 | 0.01 | 9.8e-03 | 6.8 | -7.2 | 7.2e-13 | -0.67 | 0.02 | 0.93 | FALSE |
34 | METSIM | Adipose | POMT2 | 0.04 | 0.00 | blup | 553 | 0.00 | 6.0e-02 | 4.1 | 5.3 | 1.1e-07 | 0.27 | 0.15 | 0.05 | FALSE |
35 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C14orf148 | 0.04 | 0.06 | enet | 5 | 0.07 | 1.9e-06 | 8.3 | -8.3 | 8.4e-17 | -1.00 | 0.01 | 0.99 | FALSE |
36 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AHSA1 | 0.01 | 0.01 | blup | 56 | 0.01 | 2.9e-03 | -7.6 | -7.3 | 3.4e-13 | -0.94 | 0.02 | 0.80 | FALSE |
37 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C14orf148 | 0.02 | 0.01 | blup | 53 | 0.02 | 1.1e-04 | -7.6 | -6.1 | 1.2e-09 | -0.87 | 0.05 | 0.90 | FALSE |
38 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C14orf174 | 0.02 | 0.02 | lasso | 2 | 0.02 | 6.0e-05 | 8.3 | 8.3 | 7.5e-17 | 1.00 | 0.01 | 0.99 | FALSE |
39 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | VIPAR | 0.07 | 0.02 | enet | 9 | 0.06 | 5.6e-04 | -6.8 | 6.2 | 7.1e-10 | 0.68 | 0.02 | 0.70 | FALSE |
40 | The Cancer Genome Atlas | Colon Adenocarcinoma | C14orf148 | 0.04 | 0.02 | blup | 53 | 0.03 | 5.2e-03 | 8.4 | -8.1 | 5.5e-16 | -0.97 | 0.01 | 0.85 | FALSE |
41 | The Cancer Genome Atlas | Glioblastoma Multiforme | C14orf174 | 0.11 | 0.05 | blup | 43 | 0.04 | 1.7e-02 | -7.7 | 7.9 | 2.6e-15 | 0.90 | 0.01 | 0.53 | FALSE |
42 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C14orf148 | 0.03 | 0.04 | lasso | 3 | 0.03 | 3.1e-04 | 7.7 | -7.2 | 6.4e-13 | -0.89 | 0.05 | 0.94 | FALSE |
43 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | ISM2 | 0.06 | 0.02 | enet | 6 | 0.03 | 8.3e-05 | -2.9 | -6.4 | 1.4e-10 | -0.18 | 0.01 | 0.83 | FALSE |
44 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AHSA1 | 0.02 | 0.04 | blup | 56 | 0.03 | 1.7e-04 | -7.6 | -6.4 | 1.1e-10 | -0.94 | 0.02 | 0.98 | FALSE |
45 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C14orf148 | 0.02 | 0.02 | enet | 5 | 0.01 | 1.1e-02 | 8.4 | -8.5 | 2.8e-17 | -0.99 | 0.01 | 0.89 | FALSE |
46 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C14orf174 | 0.02 | 0.00 | blup | 43 | 0.02 | 4.4e-03 | -7.7 | 7.0 | 2.3e-12 | 0.91 | 0.01 | 0.76 | FALSE |
47 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C14orf174 | 0.05 | 0.04 | lasso | 2 | 0.06 | 3.7e-04 | 3.6 | 6.5 | 1.1e-10 | 0.80 | 0.01 | 0.89 | FALSE |
48 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C14orf148 | 0.10 | 0.08 | blup | 53 | 0.10 | 2.6e-11 | -7.7 | -7.7 | 1.1e-14 | -0.89 | 0.06 | 0.94 | FALSE |
49 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C14orf174 | 0.03 | 0.03 | blup | 43 | 0.03 | 2.3e-04 | 8.4 | 8.2 | 2.8e-16 | 0.95 | 0.01 | 0.97 | FALSE |
50 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | C14orf148 | 0.11 | 0.02 | blup | 53 | 0.04 | 6.7e-03 | 8.3 | -8.4 | 6.6e-17 | -0.91 | 0.01 | 0.87 | FALSE |
51 | The Cancer Genome Atlas | Lung Adenocarcinoma | C14orf174 | 0.02 | 0.03 | lasso | 1 | 0.02 | 6.1e-04 | -7.7 | 7.7 | 1.0e-14 | 0.96 | 0.01 | 0.96 | FALSE |
52 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | C14orf148 | 0.05 | 0.01 | blup | 53 | 0.02 | 2.2e-03 | -7.7 | -8.3 | 1.0e-16 | -0.93 | 0.02 | 0.97 | FALSE |
53 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C14orf174 | 0.07 | 0.03 | blup | 43 | 0.08 | 5.8e-06 | 8.4 | 7.1 | 1.7e-12 | 0.80 | 0.01 | 0.98 | FALSE |
54 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C14orf148 | 0.06 | 0.09 | lasso | 7 | 0.07 | 4.8e-04 | -7.7 | -7.7 | 1.8e-14 | -0.97 | 0.03 | 0.92 | FALSE |
55 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | C14orf148 | 0.09 | 0.07 | blup | 53 | 0.07 | 1.3e-03 | 7.7 | -7.6 | 2.1e-14 | -0.97 | 0.03 | 0.88 | FALSE |
56 | The Cancer Genome Atlas | Prostate Adenocarcinoma | AHSA1 | 0.02 | 0.02 | enet | 5 | 0.02 | 4.0e-03 | -7.7 | -7.7 | 1.1e-14 | -0.98 | 0.02 | 0.91 | FALSE |
57 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C14orf148 | 0.05 | 0.05 | blup | 53 | 0.05 | 2.5e-06 | -7.7 | -7.7 | 1.1e-14 | -0.97 | 0.02 | 0.98 | FALSE |
58 | The Cancer Genome Atlas | Soft Tissue Sarcoma | C14orf174 | 0.04 | 0.02 | enet | 10 | 0.00 | 1.7e-01 | 5.8 | 7.4 | 1.6e-13 | 0.83 | 0.02 | 0.81 | FALSE |
59 | The Cancer Genome Atlas | Thyroid Carcinoma | AHSA1 | 0.03 | 0.03 | enet | 7 | 0.03 | 9.9e-04 | 7.7 | -8.1 | 7.0e-16 | -0.94 | 0.02 | 0.96 | FALSE |
60 | The Cancer Genome Atlas | Thyroid Carcinoma | C14orf148 | 0.03 | 0.01 | enet | 8 | 0.01 | 5.0e-02 | 7.7 | -6.9 | 5.3e-12 | -0.83 | 0.03 | 0.85 | FALSE |
61 | The Cancer Genome Atlas | Thyroid Carcinoma | C14orf174 | 0.11 | 0.14 | enet | 11 | 0.14 | 6.2e-14 | -7.7 | 7.9 | 2.1e-15 | 0.98 | 0.02 | 0.98 | FALSE |
62 | The Cancer Genome Atlas | Thyroid Carcinoma | GSTZ1 | 0.19 | 0.05 | lasso | 4 | 0.12 | 1.1e-11 | -4.4 | -5.8 | 5.7e-09 | -0.34 | 0.93 | 0.00 | FALSE |